CClinicalTrials.gg
CompletedNCT05374239Updated May 21, 2024

Embedding the Fugl-Meyer Assessment in Occupational Therapists' Routine Practice

An interventional study of Multi-component implementation intervention in Implementation Science and Stroke, sponsored by Singapore General Hospital. Completed at 1 site in Singapore. Per ClinicalTrials.gov, last updated 2024-05-21.

Sponsored by Singapore General Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Sex
All
01

Study summary

Background: Using outcome measures is emphasized in foundational training and clinical practice guidelines, but less than 50% of rehabilitation professionals consistently use outcome measures in practice. No studies have evaluated the barriers to routine outcome measurement in Singapore's healthcare settings nor identified effective implementation strategies to sustain the use of outcome measures in practice.

Aims: To evaluate the effectiveness of a tailored multi-component implementation intervention effectiveness in improving the consistency of use of the Fugl-Meyer Assessment of Upper Extremity (FMA) among occupational therapists practicing in 4 hospitals in Singapore.

Method: The project will use the Normalisation Process Theory as a framework and data collection sites will include Singapore General Hospital, Sengkang General Hospital, Outram Community Hospital, and Sengkang Community Hospital. The investigators will use a stepped-wedge randomised trial design. The study will begin with an initial period in which no hospitals are exposed to the intervention. Subsequently, at regular intervals, one hospital will cross from the control to the intervention. The investigators will continue this process until the intervention is introduced to all hospitals. The intervention will be fully implemented by the end of the trial, with all 4 hospitals receiving the multi-component intervention.

Project Significance: This trial is part of a larger project that uses a theory-driven approach to systematically explore the embedding and integration of outcome measures in routine clinical care for rehabilitation professionals in Singapore (beyond initial implementation stages). Study findings will contribute to the scientific knowledge base of implementing outcome measures in clinical practice, improve patient care, and support future implementation projects on outcome measurement in different populations and healthcare settings.

Read the detailed description

Study Hypothesis:

The null hypothesis is there is no change in the average rate of adherence to the administration to the FMA 6 months post-intervention. The alternate hypothesis is there is a significant improvement in the average rate of adherence to the administration of the FMA 6 months post-intervention.

Study Design:

The investigators will use a stepped-wedge randomized trial to evaluate the effectiveness of the implementation strategy (i.e. intervention), which involves a sequential crossover of hospitals from the control to the intervention arm (Figure 3). The study will begin with an initial period in which no hospitals are exposed to the intervention. Subsequently, at regular intervals (2 month duration), one hospital will cross from the control to the intervention. The investigators will continue this process until the intervention is introduced to all hospitals. The intervention will be fully implemented by the end of the trial, with all 4 hospitals receiving the intervention. The trial will include the 4 hospitals based on convenience sampling.

Intervention:

This trial will be conducted as part of a larger research project that uses a theory-driven approach to systematically explore the embedding and integration of outcome measures in routine clinical care for rehabilitation professionals in Singapore. The multi-component implementation strategy (i.e. intervention) will be developed in earlier phases of the larger project.

Outcomes:

The primary endpoint will be the average rate of adherence to the administration of the FMA 6 months post-intervention.

Randomisation:

Hospital will be the unit of randomisation. The investigators will employ simple randomisation using concealed envelopes.

Blinding:

Due to the nature of intervention, blinding may not be possible. However, occupational therapists at all 4 hospitals will be blinded to the allocation sequence, with only the next hospital randomised for rollout being revealed at each intervention implementation time point. This will allow for blinding to the intervention partially possible. The investigators will also remind occupational therapists at all 4 hospitals not disclose details about the intervention to other healthcare professionals until the end of the trial.

02

Conditions studied

  • Implementation Science
  • Stroke

Browse trials for

Keywords

  • implementation
  • outcome measures
  • stroke
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 4 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Singapore General Hospital is the lead sponsor of 266 studies on the registry; 57 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

A total of 4 acute and hospitals will be part of the study. These hospitals were identified through convenience sampling based on the following criteria:

Inclusion criteria

Inclusion Criteria:

  • Affiliated to SingHealth
  • Currently using FMA in clinical practice by occupational therapists

Exclusion criteria

Exclusion Criteria:

  • Use of FMA in clinical practice by occupational therapists funded by existing research grants
  • Not using FMA in clinical practice by occupational therapists
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
4 participants (actual)

Study arms

  • Other
    Hospital 1

    First hospital in the allocation sequence to cross from control to intervention arm.

    Other: Multi-component implementation intervention

  • Other
    Hospital 2

    Second hospital in the allocation sequence to cross from control to intervention arm.

    Other: Multi-component implementation intervention

  • Other
    Hospital 3

    Third hospital in the allocation sequence to cross from control to intervention arm.

    Other: Multi-component implementation intervention

  • Other
    Hospital 4

    Fourth hospital in the allocation sequence to cross from control to intervention arm.

    Other: Multi-component implementation intervention

Interventions

  • OtherMulti-component implementation intervention

    The multiple-component implementation intervention will comprise of 3 key components: (1) education, (2) operational process, and (3) audit and feedback

06

What researchers measure

Primary outcomes

  1. Adherence rate

    Average rate of adherence to the administration of the FMA by occupational therapists

    Time frame: 6 months post-intervention

Other outcomes

  1. Acceptability of Intervention Measure (AIM)

    Brief 4-item pragmatic measure of implementation outcome. Each item is rated on a 5-point ordinal scale.

    Time frame: 6 months post-intervention

  2. Intervention Appropriateness Measure (IAM)

    Brief 4-item pragmatic measure of implementation outcome. Each item is rated on a 5-point ordinal scale.

    Time frame: 6 months post-intervention

  3. Feasibility of Intervention Measure (FIM)

    Brief 4-item pragmatic measure of implementation outcome. Each item is rated on a 5-point ordinal scale.

    Time frame: 6 months post-intervention

07

Study locations

1 site
  • Singapore General Hospital
    Singapore, Singapore
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05374239
Lead sponsor
Singapore General Hospital
Collaborators
Sengkang General Hospital, Sengkang Community Hospital, Outram Community Hospital
Responsible party
Sponsor
First posted
May 16, 2022
Start date
Jul 6, 2022
Primary completion
Aug 2, 2023
Completion
Aug 2, 2023
Last update
May 21, 2024

Study contacts

Silvana Choo, PhD
principal investigator · Singapore General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion